UnitedHealth Group Incorporated $UNH Stock: Trillium Asset Management LLC Lowers Position

Trillium Asset Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 12.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,537 shares of the healthcare conglomerate’s stock after selling 1,956 shares during the period. Trillium Asset Management LLC’s holdings in UnitedHealth Group were worth $4,970,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Corient Private Wealth LP purchased a new stake in UnitedHealth Group in the 2nd quarter worth $245,516,000. Legal & General Group Plc purchased a new position in UnitedHealth Group during the second quarter valued at $2,444,928,000. Jupiter Topco LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $2,019,844,000. BlackRock Inc. increased its stake in shares of UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of UnitedHealth Group during the second quarter worth about $971,757,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.19% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. New Street Research set a $402.00 price target on shares of UnitedHealth Group in a research note on Friday, October 9th. TD Cowen reiterated a “hold” rating and set a $402.00 price objective on shares of UnitedHealth Group in a research note on Thursday, October 15th. Weiss Ratings raised UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Barclays decreased their target price on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 14th. Finally, Morgan Stanley lifted their price target on UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 27th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $463.93.

Read Our Latest Analysis on UnitedHealth Group

Recent UnitedHealth Group Headlines

Investors following UNH have been watching these headlines:

UnitedHealth Group Stock Up 0.0%

Shares of NYSE:UNH opened at $407.62 on Monday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The business has a fifty day moving average of $391.36 and a two-hundred day moving average of $365.66. The stock has a market cap of $365.23 billion, a P/E ratio of 23.28, a PEG ratio of 1.47 and a beta of 0.51. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The business had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company’s revenue for the quarter was down .4% on a year-over-year basis. During the same period last year, the company earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.